Product
Double-Blind Placebo
2 clinical trials
2 indications
Indication
COVID-19Indication
Ulcerative ColitisClinical trial
A Double-blind, Randomized, Placebo-controlled, Phase 1, Single-dose, Dose-escalating Trial of Long-acting Recombinant Human IL-7 (NT-I7) for COVID-19Status: Terminated, Estimated PCD: 2021-07-21
Clinical trial
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of CBP-307 in Subjects With Moderate to Severe Ulcerative Colitis (UC)Status: Completed, Estimated PCD: 2022-02-23